Respiratory care year in review 2010: Part 2. invasive mechanical ventilation, noninvasive ventilation, pediatric mechanical ventilation, aerosol therapy

Respiratory Care

Volumn 56, Issue 5, 2011, Pages 667-680

  Macintyre, Neil R ^a   Nava, Stefano ^b   Diblasi, Robert M ^c   Restrepo, Ruben D ^d   Hess, Dean R ^e  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SEATTLE CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aerosol therapy; Airway pressure release ventilation; Highfrequency oscillatory ventilation; Inhaled bronchodilator; Inhaled corticosteroid; Mechanical ventilation

Indexed keywords

ADRENALIN; AMIKACIN; ANTIBIOTIC AGENT; ARFORMOTEROL; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CIPROFLOXACIN; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; GSK 256066; INDACATEROL; MANNITOL; MOMETASONE FUROATE; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; PHOSPHODIESTERASE IV INHIBITOR; PLACEBO; SALBUTAMOL; SALMETEROL; SODIUM CHLORIDE; TIOTROPIUM BROMIDE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AIRWAY OBSTRUCTION; AIRWAY PRESSURE; ALLERGIC ASTHMA; ARTIFICIAL VENTILATION; ASTHMA; BRONCHIOLITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; EVENING DOSAGE; EXTUBATION; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; INVASIVE MECHANICAL VENTILATION; LUNG GAS EXCHANGE; NONINVASIVE MECHANICAL VENTILATION; PEDIATRIC MECHANICAL VENTILATION; POSITIVE END EXPIRATORY PRESSURE; PSEUDOMONAS INFECTION; RESPIRATORY CARE; RESPIRATORY FAILURE; REVIEW; SLEEP DISORDERED BREATHING; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA;

ADMINISTRATION, INHALATION; AEROSOLS; HUMANS; RESPIRATION, ARTIFICIAL; RESPIRATORY THERAPY; RESPIRATORY TRACT DISEASES; RETROSPECTIVE STUDIES;

EID: 79957565012     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.01310     Document Type: Review

References (79)

1. Rubin BK, Dhand R, Ruppel GL, Branson RD, Hess DR. Respiratory care year in review 2010. Part 1: asthma, chronic obstructive pulmonary disease, pulmonary function testing, ventilator-associated pneumonia. Respir Care 2011;56(4):488-502.
2. Brower RG, Lanken PN, MacIntyre N, Matthay MA, Morris A, Ancukiewicz M, Schoenfeld D, Thompson BT; National Heart, Lung, and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004;22:351(4):327-336.
3. Meade MO, Cook DJ, Guyatt GH, Slutsky AS, Arabi YM, Cooper DJ, et al; Lung Open Ventilation Study Investigators. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6):637-645.
4. Mercat A, Richard JC, Vielle B, Jaber S, Osman D, Diehl JL, et al; Expiratory Pressure (Express) Study Group. Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. JAMA 2008;299(6): 646-655.
5. Briel M, Meade M, Mercat A, Brower RG, Talmor D, Walter SD, et al. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA 2010;303(9):865-873.
6. Myers TR, MacIntyre NR. Respiratory controversies in the critical care setting. Does airway pressure release ventilation offer important new advantages in mechanical ventilator support? Respir Care 2007; 52(4):452-460.
7. Maxwell RA, Green JM, Waldrop J, Dart BW, Smith PW, Brooks D, et al. A randomized prospective trial of airway pressure release ventilation and low tidal volume ventilation in adult trauma patients with acute respiratory failure. J Trauma 2010;69(3):501-510.
8. González M, Arroliga AC, Frutos-Vivar F, Raymondos K, Esteban A, Putensen C, et al. Airway pressure release ventilation versus assist-control ventilation: a comparative propensity score and international cohort study. Int Care Med 2010;36(5):817-827.
9. Sud S, Sud M, Friedrich JO, Meade MO, Ferguson ND, Wunsch H, Adhikari NK. High frequency oscillation in patients with acute lung injury and acute respiratory distress syndrome (ARDS): systematic review and meta-analysis. BMJ 2010;340:c2327.
10. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342(18):1301-1308.
11. Chung KK, Wolf SE, Renz EM, Allan PF, Aden JK, Merrill GA, et al. High frequency percussive ventilation and low tidal volume ventilation in burns: a randomized controlled trial. Crit Care Med 2010; 38(10):1970-1977.
12. Allan PF. High-frequency percussive ventilation: pneumotachograph validation and tidal volume analysis. Respir Care 2010;55(6):734-740.
13. Short K, Bougatef A, Khusid F, Kenney BD, Miller K. High-frequency percussive ventilation (letter). Respir Care 2010;55(12):1762-1764;author reply:1764-1767.
14. Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, et al. ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363(12):1107-1116.
15. Dreher M, Kabitz HJ, Burgardt V, Walterspacher S, Windisch W. Proportional assist ventilation improves exercise capacity in patients with obesity. Respiration 2010;80(2):106-111.
16. Moderno EV, Yamaguti WP, Schettino GP, Kairalla RA, Martins MA, Carvalho CR. Effects of proportional assisted ventilation on exercise performance in idiopathic pulmonary fibrosis patients. Respir Med 2010;104(1):134-141.
17. Coisel Y, Chanques G, Jung B, Constantin JM, Capdevila X, Matecki S, et al. Neurally adjusted ventilatory assist in critically ill postoperative patients: a crossover randomized study. Anesthesiology 2010;113(4):925-935.
18. Terzi N, Pelieu I, Guittet L, Ramakers M, Seguin A, Daubin C, et al. Neurally adjusted ventilatory assist in patients recovering spontaneous breathing after acute respiratory distress syndrome: physiological evaluation. Crit Care Med 2010;38(9):1830-1837.
19. Bengtsson JA, Edberg KE. Neurally adjusted ventilatory assist in children: an observational study. Pediatr Crit Care Med 2010;11(2): 253-257.
20. Pierson DJ. Patient-ventilator interaction. Respir Care 2011;56(2): 214-228.
21. Bierer GB, Soo Hoo GW. Noninvasive ventilation for acute respiratory failure: a national survey of veterans affairs hospitals. Respir Care 2009;54(10):1313-1320.
22. Hess DR, Pang JM, Camargo CA. A survey of the use of noninvasive ventilation in academic emergency departments in the United States. Respir Care 2009;54(10):1306-1312.
23. Crimi C, Noto A, Princi P, Esquinas A, Nava S. A European survey of noninvasive ventilation practice. Eur Respir J 2010;36(2):362-369.
24. Epstein SK, Ciubotaru RL, Wong JB. Effect of failed extubation on the outcome of mechanical ventilation. Chest 1997;112(1):186-192.
25. Epstein SK, Ciubotaru RL. Independent effects of etiology of failure and time to reintubation on outcome for patients failing extubation. Am J Respir Crit Care Med 1998;158(2):489-493.
26. Ferrer M, Sellarés J, Valencia M, Carrillo A, Gonzalez G, Badia JR, et al. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet 2009;374(9695):1082-1088.
27. Boeken U, Schurr P, Kurt M, Feindt P, Lichtenberg A. Early reintubation after cardiac operations: impact of nasal continuous positive airway pressure (nCPAP) and noninvasive positive pressure ventilation (NPPV). Thorac Cardiovasc Surg 2010;58(7):398-402.
28. Nin N, Soto L, Hurtado J, Lorente JA, Buroni M, Arancibia F, et al. J Crit Care 2010. DOI:10.1016/j.jcrc.2010.05.031.
29. Conti G, Larrsson A, Nava S, Navalesi P. On the role of noninvasive ventilation to treat patients during H1N1 pandemic. October 2009. http://www.ersnet.org/images/stories/pdf/on_the_role_of_non-invasive_ven tilation_niv_to_treat_patients_during_the_h1n1_influenza.pdf. Accessed February 7, 2011.
30. McCracken. The consequences of withholding noninvasive ventilation during an epidemic (letter). Respir Care 2009;54(10):1412-1413.
31. Pediatric Acute Lung Injury and Sepsis Investigators. http://pedsccm.org/palisinetwork.php. Accessed February 7, 2011.
32. Vermont Oxford Network. http://www.vtoxford.org. Accessed February 7, 2011.
33. National Institute of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development. http://www.nichd-.nih.gov. Accessed February 7, 2011.
34. Aly H. Ventilation without tracheal intubation. Pediatrics 2009; 124(2):786-789.
35. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, et al. Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79(1):26-30.
36. Lista G, Fontana P, Castoldi F, Cavigioli F, Dani C. Does sustained lung inflation at birth improve outcome of preterm infants at risk for respiratory distress syndrome? Neonatology 2011;99(1):45-50.
37. Lindner W, Högel J, Pohlandt F. Sustained pressure-controlled inflation or intermittent mandatory ventilation in preterm infants in the delivery room? A randomized, controlled trial on initial respiratory support via nasopharyngeal tube. Acta Paediatr 2005;94(3):303-309.
38. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al. Early CPAP versus surfactant in extremely preterm infants. N Engl J Med 2010;362(21):1970-1979.
39. Finer NN, Carlo WA, Walsh MC, Rich W, Gantz MG, Laptook AR, et al. Early CPAP versus surfactant in extremely preterm infants. Erratum in: N Engl J Med 2010;362(23):2235.
40. SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network; Carlo WA, Finer NN, Walsh MC, Rich W, Gantz MG, Laptook AR, et al. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med 2010;362(21):1959-1969.
41. Sandri F, Plavka R, Ancora G, Simeoni U, Stranak Z, Martinelli S, et al; CURPAP Study Group. Prophylactic or early selective surfactant combined with nCPAP in very preterm infants. Pediatrics 2010; 125(6):e1402-e1409.
42. Courtney SE, Kahn DJ, Singh R, Habib RH. Bubble and ventilatorderived nasal continuous positive airway pressure in premature infants: work of breathing and gas exchange. J Perinatol 2011;31(1): 44-50.
43. Pillow JJ, Travadi JN. Bubble CPAP: is the noise important? An in vitro study. Pediatr Res 2005;57(6):826-830.
44. Pillow JJ, Hillman N, Moss TJ, Polglase G, Bold G, Beaumont C, et al. Bubble continuous positive airway pressure enhances lung volume and gas exchange in preterm lambs. Respir Crit Care Med 2007;176(1):63-69.
45. DiBlasi RM, Zignego JC, Smith CV, Hansen TN, Richardson CP. Effective gas exchange in paralyzed juvenile rabbits using simple, inexpensive respiratory support devices. Pediatr Res 2010;[Epub ahead of print]
46. DiBlasi RM, Zignego JC, Tang DM, Hildebrandt J, Smith CV, Hansen TN, Richardson CP. Noninvasive respiratory support of juvenile rabbits by high-amplitude bubble continuous positive airway pressure. Pediatr Res 2010;67(6):624-629.
47. Ancora G, Maranella E, Grandi S, Pierantoni L, Guglielmi M, Faldella G. Role of bilevel positive airway pressure in the management of preterm newborns who have received surfactant. Acta Paediatr 2010;99(12):1807-1811.
48. Lista G, Castoldi F, Fontana P, Daniele I, Cavigioli F, Rossi S, et al. Nasal continuous positive airway pressure (CPAP) versus bi-level nasal CPAP in preterm babies with respiratory distress syndrome: a randomized control trial. Arch Dis Child Fetal Neonatal Ed 2010; 95(2):F85-F89.
49. van Kaam AH, Rimensberger PC, Borensztajn D, De Jaegere AP. Neovent Study Group. Ventilation practices in the neonatal intensive care unit: a cross-sectional study. J Pediatr 2010;157(5):767-771.
50. Wheeler K, Klingenberg C, McCallion N, Morley CJ, Davis PG. Volume-targeted versus pressure-limited ventilation in the neonate. Cochrane Database Syst Rev 2010;(11):CD003666.
51. Cools F, Henderson-Smart DJ, Offringa M, Askie LM. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2009;(3):CD000104.
52. Cools F, Askie LM, Offringa M, Asselin JM, Calvert SA, Courtney SE, et al. PreVILIG collaboration. Elective high-frequency oscillatory versus conventional ventilation in preterm infants: a systematic review and meta-analysis of individual patients' data. Lancet 2010; 375(9731):2082-2091.
53. DiBlasi RM, Myers TR, Hess DR; American Association for Respiratory Care. Evidence-based clinical practice guideline: inhaled nitric oxide for neonates with acute hypoxic respiratory failure. Respir Care 2010;55(12):1717-1745.
54. Rotta ET, Amantéa SL, Froehlich PE, Becker A. Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence? Eur J Clin Pharmacol 2010;66(6):605-610.
55. Kaashmiri M, Shepard J, Goodman B, Lincourt WR, Trivedi R, Ellsworth A, Davis AM. Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. Pediatr Emerg Care 2010;26(3):197-202.
56. Donohue JF, Fogarty C, Lötvall J, Mahler DA, Worth H, Yorgancioglu A, et al. INHANCE Study Investigators. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med 2010;182(2):155-162.
57. Ryan S, Doherty LS, Rock C, Nolan GM, McNicholas WT. Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. Respiration 2010;79(6):475-481.
58. Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, Hanrahan JP. The safety and efficacy of arformoterol and formoterol in COPD. COPD 2010;7(1):17-31.
59. Rau-Berger H, Mitfessel H, Glaab T. Tiotropium Respimat improves physical functioning in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2010;5:367-373.
60. Bateman E, Singh D, Smith D, Disse B, Towse L, Massey D, et al. Efficacy and safety of tiotropium Respimat SMI in COPD in two 1-year randomized studies. Int J Chron Obstruct Pulmon Dis 2010; 5:197-208.
61. Ichinose M, Fujimoto T, Fukuchi Y. Tiotropium 5 μg via Respimat and 18 μg via HandiHaler; efficacy and safety in Japanese COPD patients. Respir Med 2010;104(2):228-236.
62. Turpeinen M, Pelkonen AS, Nikander K, Sorva R, Selroos O, Juntunen-Backman K, Haahtela T. Bone mineral density in children treated with daily or periodical inhaled budesonide: the Helsinki Early Intervention Childhood Asthma study. Pediatr Res 2010;68(2): 169-173.
63. Kosoglou T, Cutler DL, Staudinger H, Herron JM. Once-daily evening dosing of mometasone furoate administered via a dry powder inhaler does not adversely affect the hypothalamic-pituitary-adrenal axis. Chest 2010;137(1):115-121.
64. Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med 2010;10:1.
65. Singh D, Petavy F, Macdonald AJ, Lazaar AL, O'Connor BJ. The inhaled phosphodiesterase 4 inhibitor GSK256066 reduces allergen challenge responses in asthma. Respir Res 2010;11:26.
66. Berger WE, Bleecker ER, O'Dowd L, Miller CJ, Mezzanotte W. Efficacy and safety of budesonide/formoterol pressurized metereddose inhaler: randomized controlled trial comparing once- and twicedaily dosing in patients with asthma. Allergy Asthma Proc 2010;(1): 49-59.
67. Aalbers R, Boorsma M, van der Woude HJ, Jonkers RE. Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. Respir Res 2010;11:66.
68. Kuna P. Treatment comparison of budesonide/formoterol with salmeterol/ fluticasone propionate in adults aged >16 years with asthma: post hoc analysis of a randomized, double-blind study. Clin Drug Investig 2010;30(9):565-579.
69. Scichilone N, Battaglia S, Sorino C, Paglino G, Martino L, Paternò A, et al. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. Allergy 2010;65(7):897-902.
70. 2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children. Cochrane Database Syst Rev 2010;(5):CD005535.
71. Peters SP, Kunselman SJ, Icitovic N, Moore WC, Pascual R, Ameredes BT, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med 2010;363(18):1715-1726.
72. Luo Z, Liu E, Luo J, Li S, Zeng F, Yang X, Fu Z. Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. Pediatr Int 2010;52(2):199-202.
73. Al-Ansari K, Sakran M, Davidson BL, El Sayyed R, Mahjoub H, Ibrahim K. Nebulized 5% or 3% hypertonic or 0.9% saline for treating acute bronchiolitis in infants. J Pediatr 2010;157(4):630-634.
74. Anil AB, Anil M, Saglam AB, Cetin N, Bal A, Aksu N. High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. Pediatr Pulmonol 2010;45(1):41-47.
75. Amin R, Subbarao P, Jabar A, Balkovec S, Jensen R, Kerrigan S, et al. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function. Thorax 2010;65(5):379-383.
76. Daviskas E, Anderson SD, Jaques A, Charlton B. Inhaled mannitol improves the hydration and surface properties of sputum in patients with cystic fibrosis. Chest 2010;137(4):861-868.
77. Adi H, Young PM, Chan HK, Agus H, Traini D. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease. Eur J Pharm Sci 2010;40(3):239-247.
78. Noah TL, Ivins SS, Abode KA, Stewart PW, Michelson PH, Harris WT, et al. Inhaled versus systemic antibiotics and airway inflammation in children with cystic fibrosis and Pseudomonas. Pediatr Pulmonol 2010;45(3):281-290.
79. Luyt CE, Clavel M, Guntupalli K, Johannigman J, Kennedy JI, Wood C, et al. Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia. Crit Care 2009;13(6):R200.